The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)

• Status: Completed
• Trial end date: 2007-01-01
• Target enrollment: 0
• Participant gender: Male

Summary

A study to test the effects of study drug (MK 0633) on patients with Atherosclerotic disease

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.

Criteria

Inclusion Criteria:

• Patients with plaque in coronary or leg arteries, known as atherosclerosis or peripheral vascular disease

• Inflammatory marker found in your blood, known as hsCRP > 0.5 mg/L

Exclusion Criteria:

• Age < 40 or > 85

• Female

• Heart attack, coronary artery bypass, stroke or unstable angina in last 3 months

• Liver diseased or abnormalities

• HIV infection

• Lupus, rheumatoid arthritis, cancer <5 years